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Gene expression is tightly regulated in a tuneable, cell-specific and time-dependent
manner. Recent advancement in epigenetics and non-coding RNA (ncRNA) revolutionized
the concept of gene regulation. In order to regulate the transcription, ncRNA can promptly
response to the extracellular signals as compared to transcription factors present in the
cells. microRNAs (miRNAs) are ncRNA (∼22bp) encoded in the genome, and present as
intergenic or oriented antisense to neighboring genes. The strategic location of miRNA
in coding genes helps in the coupled regulation of its expression with host genes.
miRNA together with complex machinery called RNA-induced silencing complex (RISC)
interacts with target mRNA and degrade the mRNA or inhibits the translation. CD4
T cells play an important role in the generation and maintenance of inflammation and
tolerance. Cytokines and chemokines present in the inflamed microenvironment controls
the differentiation and function of various subsets of CD4 T cells [Th1, Th2, Th17, and
regulatory CD4 T cells (Tregs)]. Recent studies suggest that miRNAs play an important
role in the development and function of all subsets of CD4 T cells. In current review, we
focused on how various miRNAs are regulated by cell’s extrinsic and intrinsic signaling,
and how miRNAs affect the transdifferentiation of subsets of CD4 T cell and controls their
plasticity during inflammation and tolerance.
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INTRODUCTION
It has been speculated that about 1.5–3% of human genome
encodes for the protein and remaining large fraction exist as
non-protein coding sequences. Extra emphasis has been given
on the effect of protein–protein and protein–DNA interaction
on regulation of gene expression. Advancement in epigenet-
ics and non-coding RNA (ncRNA) already proved that gene
expression in a specific-cell can be fine-tuned based on the
signals present in the tissue microenvironment (Esteller, 2011;
Kaikkonen et al., 2011). New generation sequencing techniques
such as RNA-seq, whole transcriptome analysis, and tiling arrays
indicated that ∼90% of genomic DNA is transcribed (Mortazavi
et al., 2008; Pan et al., 2008; Wilhelm et al., 2008; Lindberg
and Lundeberg, 2010). ncRNA like ribosomal RNA, tRNA, small
nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) are
also transcribed from the genome but never translate into pro-
tein. These ncRNA controls the transcription and translation of
the several genes (Costa, 2010). ncRNAs are comprises of a class
of heterogeneous member that ranges in size from few to sev-
eral hundred nucleotides. Based on their size and origin, they
are identified as microRNAs (miRNAs), PIWI-interacting RNAs
(piRNAs), long non-coding RNAs (lncRNAs), recently identified
Abbreviations: AGO, Argonaute; APCs, Antigen presenting cells; EAE,
Experimental autoimmune encephalomyelitis; miRNA, microRNA; MS, Multiple
sclerosis; ncRNA, Non-coding RNA; RISC, RNA-induced silencing complex;
RITS, RNA-induced transcriptional silencing; shRNA, Short hairpin RNA; Tregs,
Regulatory CD4 T cells.
enhancer RNAs (eRNAs), promoter-associated RNAs (PARs),
transcription start site-associated RNAs (TSSa-RNAs), and tran-
scription initiation RNAs (tiRNAs) (Taft et al., 2009; Esteller,
2011). ncRNAs perform several important functions that con-
trol the development, survival, cell migration, cell differentiation,
apoptosis, immune response, maintaining genome stability, and
stress responses by regulating the gene expression (Kaikkonen
et al., 2011; Tomankova et al., 2011). Among the various ncR-
NAs, miRNAs are extensively studied in the context of their role
in dynamic regulation and micromangement of transcriptome in
the various cells.
Several subsets of CD4 T cells have been identified, and they all
are developed in thymus from a common precursor T cells. Based
on the cytokine secretion and function, these cells are classified
as Th1, Th2, Th9, Th17 and regulatory CD4 T cell (Treg). Recent
studies showed that these cells are not terminally differentiated
but have potential to differentiate into other CD4 T subset (Lal
and Bromberg, 2009; O’Shea and Paul, 2010; Lal et al., 2011; Gao
et al., 2012). The differentiation of different subsets of CD4 T cells
are regulated by cytokine and other extracellular signals present
in the tissue microenvironment (Lal and Bromberg, 2009; O’Shea
and Paul, 2010; Lal et al., 2011; Gao et al., 2012). Under the influ-
ence of different extracellular inflammatory stimuli, Tregs which
have potential to suppress inflammation and help in the mainte-
nance of tolerance can transdifferentiate into the pathogenic Th1
and Th17 cells (Xu et al., 2007; Lal et al., 2011; Kanno et al.,
2012). It has been reported that under inflammatory condition
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CD4+Foxp3+ Treg (nTreg) down-regulates Foxp3 expression (a
master transcription factor for nTreg) and differentiated into the
CD4 follicular helper T cells (Tfh) (Tsuji et al., 2009). It has also
been reported that loss of Foxp3 in nTreg-induced IL-4 expres-
sion and converted into Th2 lineage leading to development of
autoimmune colitis (Wang et al., 2010). It has been shown that
helminth antigens induced the differentiation of Th2 cells into
Tfh cells (Zaretsky et al., 2009). Tfh cell can also differentiate
into other effector subsets such as Th1, Th2, and Th17 cells (Lu
et al., 2011). Bending et al. reported that under lymphopenic con-
dition, Th17 cells differentiated into Th1 cells (Bending et al.,
2009). Similarly, in presence of IFN-γ Th2 cells re-programmed
into GATA3+T-bet+ cell subset and showed combined function
of Th2 and Th1 cells (Hegazy et al., 2010). All these studies
clearly demonstrated that CD4 T cells possess fair amount of
plasticity to differentiate into various subsets of CD4 T cell lin-
eage, and inflammation in the tissue microenvironment play an
important role in this cellular re-programming. The detail cellular
and molecular mechanisms that regulate plasticity of CD4 T cell
differentiation and function are not completely understood.
Recent studies have suggested strong association of miRNAs
in many inflammatory and autoimmune diseases (Chong et al.,
2008; Tomankova et al., 2011; Contreras and Rao, 2012). In
this review, we have discussed recent advances in the under-
standing of miRNA biogenesis and its role in the development,
differentiation, and function of different subset of CD4+ T cells,
and how miRNAs regulate the plasticity of CD4 T cells during
inflammation and tolerance.
miRNA BIOGENESIS
Majority of miRNAs from introns of protein coding host genes
are transcribed by RNA polymerase II (RNA pol II). Some of
miRNAs are also formed by splicing of RNA polymerase III
products. Biogenesis of miRNA is a highly regulated multi-step
process, initially carried out into the nucleus but later pro-
cessed matured in the cytoplasm (Figure 1). In the nucleus,
FIGURE 1 | Schematic representation of miRNA biogenesis. RNA
polymerase II transcribes the miRNA gene and produces hairpin structured
pri-miRNA that contains 5′ cap and 3′ poly-A tail. In the nucleus, Drosha in
association with DGCR8, a ds-RNA-binding protein generates about
55–70nt long precursor miRNA (pre-miRNA). In eukaryotes, some
pre-miRNAs are generated from mirtrons as a product of splicing reaction.
With the help of Ran-GTP bound exportin-5 pre-miRNAs are exported from
the nucleus to cytoplasm. In the cytoplasm, Dicer together with TAR
RNA-binding protein (TRBP) or PACT removes the loop and generates
miRNA duplex from pre-miRNAs. The miRNA duplex (ds-miRNA) is then
loaded into Argonaute (AGO) proteins (in the case of humans AGO 1–4).
One of the strands of ds-mRNA called guide strand retained in the AGO
and with other effector protein factors forms miRNA-induced silencing
complex (miRISC).
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primary miRNA transcripts (pri-miRNA) a double-stranded-
RNA containing stem-loop are produced as a result of RNA
pol II driven transcription. Pri-miRNAs are further processed
by Drosha (RNase III family member) and a cofactor DGCR8,
a double-stranded-RNA-binding protein which recognize about
10 bp near hairpin structure and cleaves both strands of stem
at sites near the base of primary stem-loop, and resulting hair-
pin precursor miRNA (pre-miRNA) (Lee et al., 2003). Drosha-
independent processing of the miRNAs is also reported, especially
for those miRNA derived from intronic region as a product
of splicing reaction (Berezikov et al., 2007; Ruby et al., 2007).
Later, pre-miRNAs transported to the cytoplasm by exportin-
5 (Figure 1). Exportin-5 needs another cofactor Ran bound to
GTP for export function, and this Ran-GTP bound exportin-5
recognizes 3′ overhangs of pre-miRNA (Bohnsack et al., 2004;
Lund et al., 2004). In the cytoplasm, loop region of pre-miRNA is
removed by another RNase-III family member known as “Dicer.”
Dicer is associated with TAR RNA-binding protein (TRBP) or
PACT and produce about 22 nt long miRNA duplex from pre-
miRNA (Hutvagner et al., 2001; Chendrimada et al., 2005;
Lee et al., 2006). Together, Dicer, TRBP, or PACT along with
Argonaute 1–4 (AGO 1–4) form a complex known as RISC-
loading complex (RLC). RLC loads the guide strand (one of
the two strands which has unstable base pairing at its 5′ end)
into the RNA-inducing silencing complex (RISC) and process
the duplex-miRNA (Chendrimada et al., 2005). In human, AGO
proteins bind to the guide miRNA strand, interacts with glycine-
tryptophan protein (GW182) and finally form the major compo-
nent of miRISC (Jakymiw et al., 2005; Liu et al., 2005). miRISC
regulates the gene expression either by suppressing translation or
by mediating the deadenylation and further degradation of target
mRNA (Figure 1).
REGULATION OF miRNA BIOGENESIS
It has been reported that miRNA biogenesis is a very tightly regu-
lated process, and a number of regulatory mechanisms with neg-
ative feedback control participate in the generation of pri-miRNA
(Johnston et al., 2005; Kim et al., 2007; Turner and Slack, 2009).
Post-transcription processing of pri-miRNA provides another
layer of regulatory mechanism for miRNA biogenesis such as
Drosha inhibitory molecules like lin-28 inhibits processing of let-
7 primary transcript (Newman et al., 2008). It has been reported
that mutation in TARBP2 protein, an integral component of
Dicer1-containing complex, leads to destabilization of process-
ing machinery. It is also found that TARBP2 protein controls
post-transcriptional processing of miRNA and promotes tumor
growth (Melo et al., 2009). It has been reported that DGCR8
required for the Drosha-mediated miRNA processing and nega-
tively regulates generation of pre-miRNA (Triboulet et al., 2009).
Nuclear export of pre-miRNA by Ran-GTP bound exportin-5 can
also functionally regulate the generation of functional miRNA
(Lee et al., 2008). RNA editing has been reported to regulate
the miRNA generation by changing the sequence of pri-miRNA
or pre-miRNA leading to decreased (Kawahara et al., 2007a) or
increased (Kawahara et al., 2008) efficiency of miRNA generation,
and also alteration of miRNAs target specificity (Kawahara et al.,
2007b).
MECHANISMS OF miRNA FUNCTION
It is well-established that miRNAs regulate gene expression post-
transcriptionally, mostly by either repressing the translation or
affecting the stability of target mRNA in the cytoplasm (Figure 2).
Most of the miRNAs function in the cytoplasm but somemiRNAs
are also reported to be localized in the nucleus (such as miR-29b)
(Hwang et al., 2007) and some are secreted outside of the cells
(Valadi et al., 2007). miRNAs were also reported to positively reg-
ulate the gene expression (Vasudevan and Steitz, 2007; Vasudevan
et al., 2007; Orom et al., 2008). This suggests that variousmiRNAs
can function differently in different cell-types and can control the
development and differentiation of cells.
miRNAs REGULATE GENE EXPRESSION BY DEGRADING TARGET mRNA
There is a reciprocal correlation between expression of miR-
NAs and their target mRNAs (Huntzinger and Izaurralde, 2011).
This suggests that miRNAs function by targeting mRNA degra-
dation. miRNA binds to the target mRNA with partial base pair
complementarity. Studies in animal cells and in vitro cell-free
extract have revealed that binding of miRISC to its target mRNA
recruits deadenylase complex consist of CAF1/CCR4/NOT which
removes 3′ poly-A tail from target mRNA (Behm-Ansmant et al.,
2006; Wu et al., 2006). The deadenylation process followed by
decapping mediated by DCP1 and DCP2 together with other
protein factors. Decapped mRNAs are targeted by XRN1 a
5′–3′ exonuclease present in the cytoplasm leading to degrada-
tion of mRNA (Parker and Song, 2004; Behm-Ansmant et al.,
2006). Therefore, removal of both the ends of mature mRNA
by miRNA-mediated mechanism affects the stability of mRNA
in the cytoplasm and renders them to undergo degradation
(Figure 2).
miRNAs REGULATE GENE EXPRESSION BY REPRESSING
TRANSLATION OF TARGET mRNA
Several studies using wide variety of cells as well as in cell-free
system suggested that miRNAs repress the translation of target
mRNA at both initiation and post-initiation stages. There are sev-
eral evidences that support the inhibition of translation at initia-
tion stage such as target mRNAs having functional m7Gppp-cap
at their 5′ end were repressed whereas a synthetic non-functional
5′Appp-cap and internal ribosome entry site (IRES)-mediated
translation was unaffected (Humphreys et al., 2005; Mathonnet
et al., 2007). Using bi-cistronic construct, Pillai et al. showed that
only first cistron which had 5′ cap was affected but cistron hav-
ing IRES did not show any change in translation (Pillai et al.,
2005). Similarly, it has been reported that AGO proteins com-
pete with eIF4E for binding at 5′ cap of target mRNA and inhibit
the translation (Kiriakidou et al., 2007). These evidences clearly
suggest that miRNA-mediated repression at translation initiation
stage is cap-dependent. In contrast, it has also been reported that
miRNAs repress mRNAs that are translated by IRES-dependent
mechanism (Petersen et al., 2006; Lytle et al., 2007). Other
mechanisms regulated by miRNA (acting at post-initiation of
translation) include inhibition of elongation steps, degradation
of protein during ongoing translation, and premature termina-
tion of translation are reviewed nicely elsewhere (Huntzinger and
Izaurralde, 2011).
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FIGURE 2 | Mechanisms of miRNA-mediated gene regulation.
miRNA-mediated gene regulation mostly occurred by two ways; affecting
mRNA stability in the cells or suppressing translation of target mRNA.
miRNA-induced silencing complex (miRISC) consisting of miRNA guide strand,
AGO 1–4 (in humans) and among others trinucleotide-repeat-containing
protein GW182, altogether perform regulating function. Actively transcribing
mRNA forms a circular structure via the interaction of eIF4F (eIF4A, eIF4E,
eIf4G) with 5′ cap and poly-A-binding protein (PABP) that increases the
efficiency of translation. (A) Regulation of mRNA stability. Binding of miRISC
to 3′-UTR of target mRNA recruit the deadenylase complex consisting of
CAF1-CCR4-NOT that removes the 3′ poly-A tail. It has also been reported
that deadenylation may also leads to removal of cap by DCP (DCP1 and
DCP2)-mediated decapping (Behm-Ansmant et al., 2006). DCP1 and DCP2
along with some other factors such as EDC4, DDX6 removes 5′ m7G cap and
decapped mRNA provides a platform for 5′–3′ exonuclease (XRN1 is one of
characterized members) leading mRNA degradation (Parker and Song, 2004).
(B) Regulation of target mRNA translation. miRNAs can also regulate
translation by suppressing translation initiation (reports suggest that GW182
compete with eIF4E for 5′ cap binding during initiation stage), elongation,
co-translational protein degradation, and premature termination.
ROLE OF miRNAs IN THE IMMUNE SYSTEM
miRNAs are known to control many important processes such
as development, survival, proliferation, differentiation, and func-
tion of immune cells. Several miRNAs have been reported to
control the expression of cytokines, chemokines, growth factors,
cell adhesionmolecules, co-stimulatory molecules, and transcrip-
tion factors (Table 1). For example, over-expression of miR-181
in hematopoietic precursor cells can direct the lymphoid dif-
ferentiation into B cell lineage and inhibit development of T
cell (Chen et al., 2004). Deletion of Dicer is embryonic lethal.
However, conditional deficiency of Dicer only in early develop-
mental stage of T cells (CD4−CD8− double-negative thymocytes;
using lck-Cre model) (Lee et al., 2001) or later T cell develop-
mental stage (CD4+ single-positive thymocytes; using CD4-Cre
model) reported to have no change in the mature CD4 or CD8
lineage choices (Cobb et al., 2005; Muljo et al., 2005). However,
deletion of Dicer in T cells showed generation of reduced num-
bers of total TCR α/β thymocytes in thymus (Cobb et al., 2005;
Muljo et al., 2005). This suggests that miRNA plays an important
role in the development of T cells in thymus. It has been reported
that deficiency of Dicer in CD4 T cells (CD4-cre model) did not
blocked IFN-γ production (Th1 lineage cytokine) even under
Th2 polarization condition. It suggests that miRNA expression
was required in each specific stage in order to control the func-
tion of the specific lineage of CD4 T cells (Muljo et al., 2005).
miRNAs were also reported to mediate antibody class switching,
formation of germinal center and activation of antigen present-
ing cells (APCs), and secretion of pro-inflammatory cytokines
(Baltimore et al., 2008). CD4+ T cells occupy central position
in the adaptive immune system, and they provide help to B cells
and CD8+ T cells for their differentiation and effector function.
Importance of various miRNAs in the differentiation and func-
tion of different subset of CD4 T cells are depicted in Figure 3.
Role of miRNAs in the immune responses are well-reviewed
elsewhere (O’Connell et al., 2012). In present review, we are
focusing on role of miRNAs in the plasticity and its function
in different subset of CD4+ T cells during inflammation and
tolerance.
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FIGURE 3 | miRNAs control the differentiation of CD4+ T helper cell
subsets. miRNAs regulates the differentiation of different effector (Th1,
Th2, Th17, and Tfh) and regulatory (Treg) sub-population of CD4+
T helper cells. miRNAs shown in green color are reported to positively
regulate whereas those in red color negatively regulate their
differentiation.
ROLE OF miRNA IN REGULATION OF Th1/Th2 BALANCE
Helper CD4+ T cells function both in contact-independent
(by secreting cytokines and chemokines) and contact-dependent
manner (by interacting with co-stimulatory molecules). IFN-γ
secreted by Th1 cells activates the APCs (macrophages, dendritic
cells, and B cells), and induces increased surface expression of
class-II MHC and co-stimulatory molecules on APCs, and boosts
the antigen presenting function of APCs. APCs secrete IL-12
which promotes phosphorylation of STAT4 that in turn induces
expression of transcription factor T-bet in CD4T cells and control
the production of IFNγ. IL-12-induced IFN-γ initiates a posi-
tive feedback loop which further promotes production of IL-12.
Positive feedback-induced production of IL-12 gives a strong Th1
response.
Several miRNAs are known to regulate the secretion of IFN-
γ and IL-12 cytokines which required for the differentiation of
Th1 cells. NK cells play important role in the innate immunity.
It has been shown that miR-132, miR-200, miR-212a regulate IL-
12 production in NK cells (Huang et al., 2011). These miRNAs
negatively regulate STAT4 and inhibit expression of IL-12 and
IFN-γ (Huang et al., 2011). In the helper CD4 T cells, miR-29a
and miR-29b inhibit production of IFN-γ by targeting T-bet and
Eomes, lineage-specific transcription factors that regulate the dif-
ferentiation of Th1 cells (Ma et al., 2011; Steiner et al., 2011).
Th1/Th2 cells are known to be involved in the various autoim-
mune and inflammatory diseases. Increased expression of miR-
27b, miR-128, and miR-340 in CD4+ T cells has been reported
in multiple sclerosis (Guerau-de-Arellano et al., 2011). These
miRNAs promote effector function of Th1 by inhibiting the pro-
liferation of Th2 cells. miR-128 represses the expression of Bim1, a
proapoptotic molecule required for stabilization of GATA3 (tran-
scription factor for Th2 cell lineage), whereas miR-340 down-
regulates the expression of IL-4 and together these miRNAs direct
the differentiation of Th1 cells (Guerau-de-Arellano et al., 2011).
Increased expression of miR-155 is reported in experimental
autoimmune encephalomyelitis (EAE) and promotes differentia-
tion of inflammatory Th17 cells (O’Connell et al., 2010). miR-155
also suppresses c-Maf a transactivator of IL-4 and inhibits prolif-
eration of Th2 cell (Rodriguez et al., 2007). Deficiency of miR-155
leads to excessive Th2 response and decreased IL-17 and IL-22
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production in collagen-induced arthritis (Bluml et al., 2011).
Over-expression ofmiR-155 in activated T cells leads to the differ-
entiation of Th1 response (Banerjee et al., 2010). miR-155 target
site is also found on 3′-untranslated region of IFN-γRα, and inhi-
bition of miR-155 leads to induction of IFN-γRα (Banerjee et al.,
2010). It has been reported that miR-146 expression into naïve
CD4 T cells was low but showed increased expression into effector
Th1 (Monticelli et al., 2005) and Treg (Cobb et al., 2006), but not
in Th2 cells (Monticelli et al., 2005). miR-150 expressed in naïve
CD4 T cells but down-regulated after activation and differentia-
tion into Th1, Th2, and Treg (Monticelli et al., 2005; Cobb et al.,
2006; Curtale et al., 2010). These results suggest that various miR-
NAs involve in the regulation of Th1 and Th2 cell differentiation
and function.
It has been reported that miR-17-92 cluster was involved in
the generation of Th1 cells. Deficiency of miR-17-92 leads to
the reduced expression of T-bet and IFN-γ and promotes dif-
ferentiation of the Foxp3+ Treg (Jiang et al., 2011). Analysis
of functional targets showed that miR-17 targets TGFβRII and
cAMP-responsive element-binding protein 1 (CREB1) and both
of these molecules are known to involved in Treg differen-
tiation. Therefore, this cluster displays a unique mechanism
that reciprocally regulates Th1 and Treg generation. Wu et al.
showed that miR-21 expression was inversely correlated with
IL-12 production in murine APCs which further leads to reduc-
tion in IL-12-dependent differentiation of Th1 cells (Wu et al.,
2012).
miR-29b targets T-bet and IFN-γ which are signatures of Th1
cells (Smith et al., 2012). Furthermore, IFN-γ in CD4 T cells
were found to enhance miR-29b expression via STAT1 binding
to the promoter of miR-29ab1, and forms a negative feedback
loop (Smith et al., 2012). Recently, it has been reported that
expression of miRNA Let-7e was up-regulated in an encephali-
togenic CD4 T cells in EAE mice. Silencing of Let-7e expression
in vivo using antagonist anti-miR increased Th2 response and
inhibited Th1 and Th17 responses leading to attenuation of EAE
(Guan et al., 2013). This suggests that Let-7e has important role
in balancing pro-inflammatory and anti-inflammatory responses
by reciprocally tuning the function of subset of CD4 T cells.
Foster’s group has showed that miR-126 level was correlated with
the generation of inflammatory Th2 cells in the mouse model
of allergic asthma. Suppression of miR-126 expression in the
airway resulted into down-regulation of IL-4, IL-5, and IL-13
production by Th2 cells and up-regulation of Oct binding fac-
tor 1 (OBF.1), which is a negative regulator of transcription factor
PU.1 (Brunner et al., 2007). PU.1 inhibits the expression of Th2-
specific transcription factor GATA3. Thus, this study provided a
mechanism by which miR-126 promotes the generation of Th2
cells.
All these evidences indicate that several miRNAs regulates the
differentiation and function of Th1 and Th2 and controls the
pathology.
ROLE OF miRNA IN Treg CELLS
Regulatory CD4+CD25+ T cells (Tregs) play an important role
in maintaining the homeostasis and immunological tolerance by
suppressing pathogenic CD4+ T cell response (Lal and Bromberg,
2009; Lal et al., 2009). It has been reported that deletion of Dicer
in the late stage of T cell development did not interfere the pro-
cess of development and differentiation of T cells (Cobb et al.,
2005; Muljo et al., 2005). However, lck-Cre-mediated conditional
deletion of Dicer into CD4 T cells reduces the number of Foxp3+
nTreg in thymus and secondary lymphoid organ (Cobb et al.,
2006). The lack of Dicer in the CD4+ single positive stage blocks
the TGFβ-induced differentiation of Foxp3+ Treg in vitro (Cobb
et al., 2006). Deletion of Dicer in Foxp3+ Treg (Foxp3-GFP-hCre
model) leads to loss of suppression function and induces their dif-
ferentiation into T helper memory phenotype (Zhou et al., 2008).
Dicer deficiency in Foxp3+ cells leads to the development of
fatal autoimmune diseases resembling the Foxp3 knockout phe-
notype (Zhou et al., 2008). These observations clearly suggest that
miRNAs at different stages of T cell differentiation regulate dif-
ferent functions. Dicer is not only involved in the processing of
miRNA but also involved in the processing of short hairpin RNA
(shRNA). Therefore, phenotype reported in Dicer-deficient ani-
mals accounts for the loss of not only miRNA but also shRNA.
RNase III enzyme Drosha is specifically required for generating
miRNA and deletion of Drosha in the CD4 T cells leads to spon-
taneous T cell activation, inflammatory diseases, and premature
lethality (Chong et al., 2008). Ablation of Drosha specifically in
the Foxp3+ T cells leads to early onset of lymphoproliferative dis-
ease as observed in T cell or Foxp3-deficient mice (Chong et al.,
2008). These reports suggest that different miRNA processing
enzymes in CD4 T cells can affect the differentiation and function
of nTreg.
miR-155 is highly expressed in the Treg (Zheng et al., 2007).
It has been shown that Foxp3 binds to the promoter region of
bic gene, which is transcribed into miR-155 precursor mRNA
(Marson et al., 2007). Deficiency of miR-155 showed reduced
Treg in the thymus and periphery, however Treg from miR-155
deficient animal do not show any defect in suppressive function
both in vitro and in vivo (Kohlhaas et al., 2009). Furthermore,
Rudensky’s laboratory showed that deficiency of miR-155 leads
to the increased expression of suppressor of cytokine signaling
1 (SOCS1) leading to impaired activation of signal transducer
and activator of transcription factor 5 (STAT5) (Lu et al., 2009).
STAT5 signaling is required for the survival and function of Tregs.
Rudensky’s group also reported that miR146a is also prevalently
expressed in Treg cells and critical for Treg function. In addition,
they also showed that deficiency of miR146a increases the num-
ber of Tregs but impaired their function. miR146a directly targets
STAT1 which is a key transcription factor required for IFN-γ sig-
naling and Th1 differentiation thus helps in Treg function (Lu
et al., 2010). miR146a knocked out mice showed increased Th1
phenotype which is similar to specific depletion of SOCS1 (a neg-
ative regulator of STAT1) in Foxp3+ Treg leading to breakdown
of tolerance and massive autoimmune inflammation (Lu et al.,
2010).
CD4 T cell activation requires low levels of intracellular cAMP.
It has been reported that cAMP play an important role in contact-
dependent manner to control the suppressive function of nTreg.
nTreg contains high level of cAMP compared to the naïve or
effector CD4 T cells (Bopp et al., 2007). nTreg releases intra-
cellular cAMP into effector T cells through tight junction and
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suppresses the effector cell function (Bopp et al., 2007). It has
been shown that activated helper CD4 T cell contains high lev-
els of phosphodiesterase, an enzyme responsible for turnover of
cAMP. This enzyme is down regulated in the nTreg (Marson
et al., 2007; Zheng et al., 2007). It has been reported that block-
ing of cAMP degradation by phosphodiesterase 4 inhibitor lead
to increased Tregs suppressive function (Bopp et al., 2009).
Elevated levels of intracellular cAMP blocks IL-12 signaling path-
way in target cells and thus suppress its differentiation into Th1
lineage. In the same context, Huang et al. showed that down-
regulation of miR142-3p is essential for Treg function (Huang
et al., 2009). miR-142-3p maintains low levels of intracellular
cAMP by targeting adenylyl cyclase (AC) 9 mRNA (Huang et al.,
2009). In Treg cells, Foxp3 directly down-regulates miR-142-3p
expression and keeps the AC9/cAMP pathway active and elevates
intracellular cAMP levels (Huang et al., 2009). Thus, down-
regulation of miR142-3p is required for suppressor function of
Treg cells.
Comparison of miRNA expression between human naïve CD4
T cells with Treg showed altered expression of five signature
miRNAs (miR-21, -31, -125a, -181c, and -374) in Treg (Rouas
et al., 2009). miR-31 and miR-125a were strongly down-regulated
while miR-21, -181c, and -374 were found to be significantly
up-regulated in Treg cells. miR-31 is known to target Foxp3
mRNA and negatively regulates its expression. miR-21 might be
involved in positive regulation of Foxp3 expression. Functions of
remaining three miRNA in Tregs are needs to be explored (Rouas
et al., 2009). miRNA analysis of Tregs from normal and diabetic
patients showed significant increased expression of miR-510 and
decreased expression of miR-342 and miR-191 (Hezova et al.,
2010). Hezova et al. hypothesized that down-regulation of miR-
342 in Tregs and impairement of Treg function in type 1 diabetic
patients may be associated with disease progression. For better
understanding the functional significance of differential expres-
sion of miR-510, miR-342, and miR-191 in Treg during type 1
diabetes need to be further investigated.
It has been shown that Foxp3 expression in thymic-derived
Treg (nTreg) aremore stable compared to the induced Treg (iTreg)
(Zhou et al., 2008; Lal and Bromberg, 2009). It has been shown
that nTreg possess demethylated CpG residues in their regulatory
regions of the Foxp3 gene whereas it was completely methylated
in the iTreg (Floess et al., 2007; Lal et al., 2009). Exposure of
iTreg to DNA methyltransferase inhibitors leads to increased sta-
bility in the Foxp3 expression (Baron et al., 2007; Lal et al., 2009).
Inflammatory signals modulated the epigenetic marks and affect
the Foxp3 expression in Tregs (Li et al., 2010; Lal et al., 2011).
Recently, it has been shown that nTreg expresses high levels of
miR-10a and provides stability of Foxp3 expression whereas iTreg
induced with TGF-β alone does not express miR-10a, leading to
decreased stability of Foxp3 expression. It has been reported that
addition of retinoic acid (RA) together with TGF-β induces miR-
10a expression in iTreg (Jeker et al., 2012). O’Shea’s group showed
that in TGF-β and RA iTreg, miR-10a targets transcriptional
repressor Bcl6 and co-repressor Ncor2, and inhibits the differen-
tiation of iTreg to Tfh cells (Takahashi et al., 2012). It has been
shown that miR-10a inhibits T-bet-dependent Th17 differentia-
tion in iTreg and reduces the severity of EAE (Takahashi et al.,
2012). Recently, it has been demonstrated that miR-24 and miR-
210 target Foxp3mRNA and regulates human Treg differentiation
(Fayyad-Kazan et al., 2012).
These studies clearly suggest that a number of miRNAs not
only regulates the development of Treg but also controls the
plasticity and function of Treg. Disruption in Treg migration,
differentiation, and function is known to have direct impact on
controlling the inflammation and tolerance.
ROLE OF miRNA IN Th17 CELLS
Naive CD4+ T cells under the influence of IL-6 and TGF-
β differentiate into distinct subset called Th17 which secretes
IL-17A, IL-17F, and IL-22. Th17 cells are reported to play an
important role in clearance of pathogens, graft rejection, and
autoimmune diseases (Segal, 2010; Wilke et al., 2011). miR-326
has been shown to be up-regulated in Th17 cells (Du et al.,
2009). Over-expression of miR-326 in mice-induced severe EAE
which was marked by increased number of Th17 cells in CNS
as well as increased expression of Th17 signature cytokines (IL-
17A, IL-21, IL-22, IL-23R) in Th17 cells (Du et al., 2009). E26
transformation-specific-1 (Ets-1), a known negative regulator of
Th17 (Moisan et al., 2007) and acts as a functional target of
miR-326 that represses the translation of Ets-1 mRNA (Du et al.,
2009).
miR-155 has been reported to be linked with the develop-
ment of inflammatory CD4 T cells. miR-155−/− mice have been
found to produce defective Th1 and Th17 cells during EAE as well
as in mouse model of delayed type hypersensitivity (O’Connell
et al., 2010). Naive CD4+ cells from miR-155−/− mice showed
defects in in vitro differentiation of Th17 cells. GM-CSF-derived
activated myeloid dendritic cells from miR-155−/− mice were
reported to produced IL-6, IL-23p19, IL-23p40, and TNF-α in
significantly reduced amount. Since, IL-6 and IL-23 secreted by
dendritic cells are essential for Th17 cell development. It has
been suggested that miR-155 expression in dendritic cells is
required for development of inflammatory Th17 cells (O’Connell
et al., 2010). miR-155 is also associated with several autoim-
mune diseases such as EAE (Murugaiyan et al., 2011), arthritis
(Kurowska-Stolarska et al., 2011), systemic lupus erythematosus
(SLE) (Leng et al., 2011), chronic gastritis, and colitis (Oertli
et al., 2011). In contrast to these reports, expression of miR-
155 has been found to negatively regulate Th17 cells in acute
coronary syndrome patients (Yao et al., 2011). Another miRNA,
Let-7f was found to control the expression of IL-23R in mem-
ory CD4+ T cells. Memory CD4 T cells showed decreased Let 7f
and up-regulation of IL-23R in MS (Li et al., 2010). It has been
established that IL-23/IL-23R signaling is essential for the main-
tenance of Th17. Using EAE model, Mycko et al. showed that
miR-301a helps in promoting Th17 cell differentiation (Mycko
et al., 2012). They also reported that silencing ofmiR-301a in CD4
T cells resulted in down-regulation of Th17-specific gene expres-
sion and did not affect the Tbx21 and Foxp3 expression. Further
investigation in different subsets of T helper cells suggested that
miR-301a-mediated STAT3 phosphorylation is essential for the
Th17 cell differentiation program. Along with this effect, miR-
301a is known to inhibit PIAS3, a molecule known to interfere
with STAT3 signaling pathway (Chung et al., 1997). Altogether,
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these studies suggested that expression of miR-301a in CD4 T
cells contribute to the generation of inflammatory Th17 cells.
IL-17 secreting murine Th17 and γδ T cells has been found to
have increased expression of miR-133b and miR-206. These miR-
NAs were reported to present in syntenic to the Il17a/f locus and
their expression was co-regulated with IL-17 production (Haas
et al., 2011). Further investigation in human primary CD4 T
cells revealed that only CD4+IL-17A+IFNγ+ Th17 cells but not
CD4+IL-17A−IFNγ+ Th1 cells express both miR-133b and miR-
206. These reports suggest that various miRNAs differentially
regulate the transdifferentiation of Th17 cells. In brief, there are
several miRNAs that can modulate Th17 function and affect the
pathogenesis of various diseases. Modulation of Th17 function
and its epigenetic plasticity under inflammatory and tolerogenic
conditions need further thorough investigation. How do miR-
NAs fine-tune the Th17 function in secondary lymphoid organs
and inflamed microenvironment is not yet clear and need active
investigation.
FUTURE PERSPECTIVE
During infection or inflammatory conditions set for the Th1
differentiation such as infection of Toxoplasma gondii or
Mycobacterium tuberculosis, Tregs acquires Th1 phenotypes (Koch
et al., 2009; Oldenhove et al., 2009). Further analysis suggested
that T-bet+ Treg controls the Th1 response whereas T-bet− Treg
promotes Th1/Th17-mediated autoimmune diseases (Koch et al.,
2009; O’Connor et al., 2010). Neutralization of IFN-γ in graft-
vs.-host disease model ablates alloreactive Treg function leading
to necrosis and graft rejection (Sawitzki et al., 2005). A tran-
scription factor IRF4 was known to regulate the differentiation
of CD4 T cell subsets (Lohoff et al., 2002). Conditional dele-
tion of IRF4 in the Treg leads to the increased Th2 response
and pathogenesis of the diseases (Zheng et al., 2009). Apart from
the transcription factors, now several investigators are trying
to understand how do miRNAs regulate the differentiation and
function of the cells. Transgenic and knockout mouse models
provide a valuable tool to understand the physiological signif-
icance of each of these miRNAs and understanding the func-
tion and its targets in the immune cells may revolutionize the
field.
Like protein coding RNA, a numbers of ncRNAs are also
induced by inflammatory signals. The timing of miRNA expres-
sion, cell-types, and mode of action may have very unique role
in the cell differentiation and physiological function. The inter-
esting part of ncRNA-mediated gene regulation is that they
are processed quickly and do not have to undergo transla-
tion process to become functionally active. This makes them to
response promptly to the inflammatory signals and can fine-
tune the transcription. miRNAs are involved in the various
tissue inflammations and control both immune cells (which ini-
tiate antigen-specific response and produces pro-inflammatory
cytokines) and tissue stromal cells (that magnify the response
by producing chemokines that recruits monocytes and granulo-
cytes). For example, microglia cells in the brain down-regulate
miR-124 leading to its activation during EAE (Ponomarev et al.,
2011) whereas miR-155 and miR-326 expression increased in
Th17 cells, together increase the inflammation and pathogene-
sis of the diseases (Du et al., 2009; O’Connell et al., 2010). There
are several targets that are controlled by miRNA (Table 1) which
suggests that a therapeutic approach can be employed by target-
ing a specific or multiple miRNAs simultaneously in an effort to
achieve a strong and potent effect on a tissue-specific inflamma-
tion. Antigen-specific Tregs provide a valuable cellular therapy to
induce transplantation tolerance and control the autoimmunity.
However, understanding the plasticity of antigen-specific Treg
and its differentiation into antigen-specific effector T cells in vivo
due to exposure to inflammatory signals in the body imposes
a caution using such cellular therapy. Future studies to under-
stand the function of various miRNA in the Th1, Th2, Th17, and
Treg and its affect on inflammatory signals may provide a novel
therapeutic strategy to manipulate the antigen-specific Treg for
clinical use.
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